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Background. We compared Skin-sparing mastectomy (SSM) with immediate breast reconstruction and Non-skin-sparing
mastectomy (NSSM), various types of incision in SSM. Method. Records of 202 consecutive breast cancer patients were reviewed
retrospectively. Also in the SSM, three types of skin incision were used. Type A was a periareolar incision with a lateral extension,
type B was a periareolar incision and axillary incision, and type C included straight incisions, a small elliptical incision (base line
of nipple) within areolar complex and axillary incision. Results. Seventy-three SSMs and 129 NSSMs were performed. The mean
follow-up was 30.0 (SSM) and 41.1 (NSSM) months. Respective values for the two groups were: mean age 47.0 and 57; seven-year
cumulative local disease-free survival 92.1% and 95.2%; post operative skin necrosis 4.1% and 3.1%. In the SSM, average areolar
diameter in type A & B was 35.4mm, 43.0mm in type C and postoperative nipple-areolar plasty was performed 61% in type A &
B, 17% in type C, respectively. Conclusion. SSM for early breast cancer is associated with low morbidity and oncological safety that
are as good as those of NSSM. Also in SSM, Type C is far superior as regards cost and cosmetic outcomes.
1.Introduction
The establishment of modern radical surgery for breast
cancer started with standard radical mastectomy, conducted
byWilliamStewartHalstedin1882.Thisprocedureconsisted
of extensive resection of overlying skin centered around the
focus of cancer, the entire mammary gland, and the pec-
toralis major and minor muscles, as well as complete lymph
node dissection. At a time when most cases of breast cancer
were, what is now called, locally advanced or metastatic
breast cancer, the procedure was considered an operative
method to be implemented with curative intent because
the three-year survival after surgery was over 40% and the
outcomes of local control were astounding at the time [1].
The procedure was reﬁned by his second-generation
pupil, Cushman Davis Haagensen, profoundly inﬂuencing
many surgeons around the world [2].
Halsted’s procedure is based on the theory that breast
cancer progresses anatomically, that is, from the mammary
gland via the regional lymph nodes to the entire body. It was
therefore essential to resect the regional lymph nodes and
intervening lymphatics and to remove the entire mammary
gland with radical surgery. This procedure became the basis
for further extension of the surgical procedure, that is, inter-
nal mammary and supraclavicular lymph node dissection,
after the long-term postoperative results peaked in the 1920–
30s. This theory, however, rapidly lost favor after Fisher et
al. introduced new concepts [3–5], and the usefulness of
extended surgery for improving the prognosis was refuted
by a clinical trial in the early 1980s [6]. On the other hand,
the gradual movement toward limited surgery that started
in the 1950s arose primarily because the detection of breast
cancer at an early stage became possible, which was further
reinforced by the requests for this surgery from women at2 International Journal of Surgical Oncology
the time. The transition to modiﬁed radical mastectomy
progressed rapidly from 1975 to 1980 in the USA [7], and
in Japan the procedure became mainstream in the late 1980s
[8]. Later, after the NSABP (National Surgical Adjuvant
Breast Project) protocol B-06 was conducted in 1985 [9],
breastconservingsurgery(BCS)waschosenmorefrequently,
and the long-term (20-year) results demonstrated that BCS
produced outcomes comparable to mastectomy [10, 11].
Today local controlof breastcanceris the major objective
of surgical treatment and considered a part of systemic
therapy [12]. BCS is now the mainstream of breast cancer
treatment. Even now, however, about one-third of women
with breast cancer choose mastectomy, based on the size or
site of the lesion and the presence of an extensive intraductal
lesion [13].
Skin-sparing mastectomy (SSM) with immediate breast
reconstruction reported by Toth and Lappert in 1991 is
generally acknowledged to be the method that can achieve
radical cure and resolve cosmetic issues [14]. At our hos-
pital, we have adopted this method in cooperation with
plastic surgeons and have produced excellent results since
2003.
In the following sections, we report an overview of the
ﬁndings and a retrospective case control study of skin-
sparing mastectomy (SSM) and non skin-sparing mastec-
tomy (NSSM) performed by a single surgeon during the
same period.
2. Patientsand Methods
The subjects were 202 female Japanese patients who under-
went mastectomy by a single surgeon (SK) at the Jikei
University Kashiwa Hospital during the period from July
2003 to June 2010. Of these patients, 73 were assigned to the
SSM group and 129 to the NSSM group.
In the SSM group, removal of the nipple with/without
areola complex, biopsy scars (excluding the core needle
biopsy scar), and the entire breast parenchyma were planned
[15]. Immediate breast reconstruction was performed by a
plastic surgeon in all patients in the SSM group.
In the SSM group, the patients were assigned to undergo
three types of skin incision. Type A was a periareolar incision
with a lateral extension (the so-called “tennis racquet”), type
B was a periareolar incision and axillary incision, and type
C included straight incisions, a small elliptical incision (base
line of nipple) within areola complex (the so-called “areolar
sparing”) and axillary incision (Figure 1).
Appropriate adjuvant therapy was carried out for all
patients based on their own choice after they under-
went postoperative pathological examination and adequate
informed consent was obtained.
The chi-square test and t-test were used in the statistical
analysis. The cumulative overall survival (OAS), cumulative
distant disease-free survival (DDFS), and cumulative local
disease-free survival (LDFS) were calculated by the Kaplan-
Meier method, and a signiﬁcant diﬀerence was evaluated by
the Wilcoxon test (P ≤ 0.05).
3. Results
Table 1 shows the patient (73 in the SSM group and 129
in the NSSM group) and tumor characteristics and tumor
staging determined based on the American Joint Committee
on Cancer Staging System.
The mean age was 47.0 ± 9.0 (31–71) years in the SSM
group and 57.7 ± 11.9 (31–83) years in the NSSM group,
signiﬁcantly lower in the former group (P<0.000). The
mean follow-up period in the SSM group was 30.0 ± 22.6
(1–85) months, which was signiﬁcantly shorter than the 41.1
± 21.3 (1–86) months in the NSSM group (P<0.000).
Stage 0 noninvasive cancer accounted for 15.1% of the SSM
group and 7.8% of the NSSM group (P = 0.1). Neoadjuvant
chemotherapy (NAC) was carried out in four cases in the
SSM group (5.5%) and in ﬁve cases in the NSSM group
(3.9%) (P = 0.6).
Table 2 shows an overview of the operative procedures.
In the SSM group, 48.0% of the patients underwent both
total mastectomy (Bt) and axillary lymph node dissection
(ALND), 34.2% underwent sentinel lymph node biopsy
(SLNB) alone, and 17.8% additionally underwent ALND
after SLNB. In the NSSM group, the percentages were 75.9%,
20.2%, and 3.9% respectively. The average time required for
mastectomy was 140 minutes in the SSM group and 130
minutes in the NSSM group (P = 0.06); the intraoperative
bloodlosswas212gintheSSMgroupand197gintheNSSM
group (P = 0.5).
Table 3 shows the type of skin incision and type of
reconstruction, and Figure 2 shows the appearance of each
type after reconstruction. Also in Table 3, the number of
cases was compared between the ﬁrst half of the study (July
2003toJune2007)andthesecondhalfofthestudy(July2007
to June 2010) in the SSM group alone—26 cases (35.6%)
were in the ﬁrst half and 47 cases (64.4%) were in the
second half. The average operative duration decreased from
148 minutes to 132 minutes (P = 0.03), and the average
intraoperative blood loss also decreased from 232g to 196g
(P = 0.27). While type A accounted for 84.6% in the ﬁrst
half of the study, type B and C accounted for 53.2% and
38.3%, respectively, in the second half of the study (P<
0.000). The percentage of DIEP ﬂap breast reconstructions
increased from 15.4% in the ﬁrst half to 53.2% in the second
half (P = 0.002). The average length of the long axis of
the periareolar incision was 3.7cm in the SSM group. The
averagediameterwas35.4mmintypesAandBand43.0mm
in type C, respectively (P = 0.0002).
Table 4 shows the relation between nipple-areolar plasty
and type of incision. Postoperative nipple-areolar plasty was
requested in 48 cases (88.9%) and received in 33 cases
(61.1%) of types A and B and in 3 cases (16.7%) of type C,
respectively (P = 0.001).
Table 5 shows a summary of postoperative complica-
tions. Skin necrosis that required debridement and further
treatment was seen in 4.1% of the SSM group and in 3.1% of
the NSSM group, showing no signiﬁcant diﬀerence between
the two groups (P = 0.69). In the SSM group, ﬂap loss and
deep vein thrombosis (DVT) due to circulatory insuﬃciency
were each seen in 1.4%, fat lysis in the ﬂap associated withInternational Journal of Surgical Oncology 3
Table 1: Patients and tumor characteristics and stage in SSM and NSSM (%).
SSM NSSM
Number of patients 73 129
July 2003–June 2007 26 (35.6) 81 (62.8)
July 2007–June 2010 47 (64.4) 48 (37.2)
Age (yrs.) 47.0 ± 9.0 57.7 ± 11.9
Follow-up time (months) 30.0 ± 22.6 41.1 ± 21.3
Microcalciﬁcations on mammography 26 (35.6) 45 (34.9)
Multicentricity 9 (12.3) 15 (11.6)
Nipple discharge 14 (19.2) 13 (10.1)
Distance between nipple and tumor < 20mm 52 (71.2) 82 (63.6)
Stage 0: TisN0M0 11 (15.1) 10 (7.8)
Stage I:T1N0M0 25 (34.2) 33 (25.6)
Stage IIA 28 (38.4) 58 (43.0)
T1N1M0 13
T2N0M0 27 55
Stage IIB 9 (12.3) 28 (21.6)
T2N1M0 82 3
T3N0M0 15
(Neoadjuvant chemotherapy: NAC) 4 (5.5) 5 (3.9)
Table 2: Operation characteristics in SSM and NSSM (%).
SSM NSSM
Operation (mastectomy) time (min.) 140.1 ± 30.4 130.0 ± 33.8
Blood loss during mastectomy (g.) 212.0 ± 131.8 197.0 ± 146.4
Type of mastectomy
Bt + ALND 35 (48.0) 98 (75.9)
Bt + SLNB 25 (34.2) 26 (20.2)
Bt + SLNB → ALND 13 (17.8) 5 (3.9)
Bt: total mastectomy, ALND: axillary lymphnode dissection, and SLNB: sentinel lymphnode biopsy.
Table 3: Chronological changes in SSM between July 2003–June 2007 and July 2007–June 2010 in SSM (%).
July 2003–June 2007 July 2007–June 2010
Number of patients 26 (35.6) 47 (64.4)
Operation (mastectomy) time (min.) 148.3 ± 26.9 132.1 ± 50.6
Blood loss during operation (g.) 232.1 ± 174.8 196.6 ± 99.8
Type of skin incision for SSM
Type A 22 (84.6) 4 (8.5)
Type B 4(15.4) 25 (53.2)
Type C 0 (0) 18 (38.3)
Type of reconstruction following SSM
LDMC ﬂap 4 (15.4) 6 (12.8)
TRAM ﬂap 18 (69.2) 15 (31.9)
DIEP ﬂap 4 (15.4) 25 (53.2)
Silicon implant 0 1 (2.1)
LDMC: latissimus dorsi musculocutaneous, TRAM: transverse rectus abdominis musculocutaneous, and DIEP: deep inferior epigastric perforator.4 International Journal of Surgical Oncology
Type A Type C Type B
Figure 1: Classiﬁcation of skin incisions for SSM.
Type A Type C Type B
Figure 2: Appearance of the breast following SSM and reconstruction with a TRAM ﬂap. Type A: left breast, type B: right breast, and type
C: left breast.
infection that required surgical approaches and a hernia at
the donor site each occurred in 2.7%.
Table 6 showsthecomplicationsobservedinsmokersand
nonsmokers in the SSM group. The combined incidences
of skin and ﬂap-related problems and DVT were 20% and
5.7%, respectively (P = 0.06). As regards local recurrence
during the follow-up period, two episodes were reported in
the SSM group (2.7%) and ﬁve episodes in the NSSM group
(3.9%). One case of cancer death was reported in the SSM
group(1.4%)andsixcaseswerereportedintheNSSMgroup
(4.7%).
Figure 3 shows the local disease-free survival (LDFS)
and overall survival (OAS) determined by the Kaplan-Meier
method. Seven-year LDFS was 92.1% in the SSM group and
95.2% in the NSSM group (P = 0.75), and seven-year OAS
was 96.9% in the SSM group and 90.1% in the NSSM group
(P = 0.69). There was no signiﬁcant diﬀerence in rates
between the two groups.
Table 4: Relations between nipple-areolar complex and type of
incision (%).
Desire for NAP No desire for
NAP
Received Not received
Types A and B 48 (88.9) 33 (61.1) 15 (27.8) 6 (11.1)
Type C 3 (16.7) 3 (16.7) — 15 (83.3)
NAP: nipple-areolar plasty.
4. Discussion
SSM with immediate breast reconstruction has rapidly
spread during the past 20 years, and its origin dates back
to subcutaneous mastectomy, ﬁrst performed by Freeman
in1962 [16].International Journal of Surgical Oncology 5
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Figure 3: Kaplan-Meier survival curve for SSM and NSSM. (a) Local disease-free survival P = 0.75. (b) Overall survival P = 0.69.
Table 5: Complications in SSM and NSSM (%).
SSM NSSM
Postoperative hemorrhage 1 (1.4) 0
Skin necrosis 3 (4.1) 4 (3.1)
DVT 1 (1.4) 0
Flap loss 1 (1.4) 0
Fat lysis of ﬂap with infection 2 (2.7) 0
Hernia at donor site 2 (2.7) 0
DVT: deep vein thrombosis.
In SSM, the nipple-areolar complex and all biopsy
scars excluding the core needle biopsy scar are resected,
inframammary fold and most of the native breast skin are
preserved, and the entire breast parenchyma is removed.
Usually SSM is followed by immediate breast reconstruction,
through which better cosmetic outcomes are produced, the
anesthetic risk and the patient’s emotional trauma from the
lossofabreastarereduced,and,ultimately,cost-eﬀectiveness
is achieved [17, 18].
The mean age of the SSM group is generally lower than
that of the NSSM group [15]. This may reﬂect bias not only
among patients who choose the operative procedure but also
oncological surgeons who propose the operative procedure.
We believe that the follow-up period was signiﬁcantly
shorter in the SSM group in this case series because 64% of
SSMs were performed in the second half.
Inviewoftheanatomicalcourseofducts,resectionofthe
nipple-areolar complex has been considered to be essential
becausethetumorcellsmayspreadtotheadjacentducts.The
involvement of tumor cells at the nipple-areolar complex is
reported to occur in about 3–10%, except for the extremely
Table 6: Relation between smoking and complications in SSM (%).
Smoker Nonsmoker
Number of patients 20 53
Troubles of skin and ﬂap 3 (15.0) 3 (5.7)
DVT 1 (5.0) 0
DVT: deep vein thrombosis.
high percentage of 58% reported in one study [13, 15]. On
the other hand, Simmons et al. examined the nipple and
areola separately and reported that areolar involvement was
seen in just 0.9% [19]. At our institution, during the second
half of this case series we tried an approach that uses the
type C skin incision while taking account of the information
obtained from preoperative, contrast-enhanced CT/MRI to
achieve better cosmetic outcomes and obtained the positive
outcomes seen in the study by Simmons et al. [20], although
our study period was relatively short.
The average areolar diameter of type C was signiﬁcantly
larger than that of types A and B. Therefore, we consider
that areolar sparing mastectomy can be performed safely in
patients with at least 4cm or more of the length of the long
axis of the areola. Also, type C is considered far superior as
regards cost and cosmetic outcomes, because the patients,
who desire to receive postoperative nipple-areolar plasty, are
signiﬁcantly fewer. Since April 2010, we have been trying to
apply the nipple-areolar complex made with silicon material
(Figure 4) instead of surgical approach.
Axillary incision is additionally performed in all type B
and type C skin incisions at our institution. This is primarily
because, in this case series: (1) it was diﬃcult to perform
total mastectomy due to the small average areolar diameter6 International Journal of Surgical Oncology
(a) (b)
Figure 4: nipple-areolar complex made with silicon material.
(3.7cm) [19], (2) 65% of the cases underwent complete level
I-IIIALND,and(3)97%ofthecaseschoseamicrovascularly
augmented TRAM ﬂap that required microscopic vascular
anastomosis not only in the DIEP ﬂap but also in the TRAM
ﬂap, and the plastic surgeon preferred an axillary incision, in
ordertousethoracodorsalvessels.Infact,anaxillaryincision
is hardly noticeable when seen from the front and we believe
it has no inﬂuence on the cosmetic outcomes.
Currently in Japan, it is diﬃcult to perform breast recon-
struction using implants because of some problems with the
medical insurance system—this is the reason why 99% of the
cases underwent reconstruction using autogenous tissues.
C o m p a r e dw i t hN S S M ,i ti sm o r ed i ﬃcult to ensure a
clearoperativeﬁeldinSSM,andSSMinvolvesmoreextensive
subcutaneous dissection. Therefore, the surgery took longer
and the intraoperative blood loss tended to be greater in
the ﬁrst half of the study. In the second half, however, the
duration of the SSM procedure and the intraoperative blood
loss were comparable to those of NSSM, despite an increase
in the percentages of type B and type C incisions, which are
supposed to have a narrower ﬁeld than the type A incision.
Webelievethisﬁndingwasgreatlyinﬂuencedbythetechnical
improvement achieved due to the accumulated experience
of a single surgeon and due to the bipolar scissors used for
subcutaneous dissection in the second half of the study.
Most of local recurrences after mastectomy occur in the
chest wall skin [13, 15]. There was therefore concern that
SSM, in which breast skin is conserved to the maximum
extent possible, may induce local recurrence. Previous stud-
ies have reported that the local recurrence rate is about 2–7%
[13, 15–18, 21–23]. It is now widely known that not only the
local recurrence rate but also the overall survival in SSM is
comparable to those in NSSM, at least for stages 0, I, and II,
as seen in the results of our case series.
A complication common to SSM and NSSM is skin
necrosis. Its incidence has been reported to be about 10%
[15, 23], and the risk of developing skin necrosis is thought
to be equal between the two groups. SSM requires some
technical considerations such as (1) avoiding the application
of excessive tension to the skin ﬂap or (2) use of a
surgical knife to make a thin skin ﬂap just over the tumor.
The relationship between skin necrosis observed in SSM and
smoking habits has often been examined, and nicotine is
thoughttobeariskfactorforskinnecrosisbecauseitreduces
capillary blood ﬂow [15–17]. In our case series, skin necrosis
occurred in 5% of nonsmokers but in 15% of smokers.
Although no prospective randomized study that com-
pares SSM and NSSM has been conducted so far, it can
be said to be commonly acknowledged that local control,
prognosis, and risk of complications are the same for SSM
and NSSM, at least in stages 0, I, and II.
SSM is still considered to be contraindicated for inﬂam-
matory breast cancer and breast cancer with skin invasion.
Although there have been some studies on the usefulness of
SSMinlocallyadvancedbreastcancer[24,25],itsapplication
is still controversial. Nonetheless, SSM is considered to be an
o p e r a t i v ep r o c e d u r et h a tc a nb eo fg r e a tb e n e ﬁ tt op a t i e n t s
with relatively early stage breast cancer who are potential
candidates for breast conservation but are ineligible for
BCS.
5. Conclusion
When SSM with immediate breast reconstruction is per-
formed in patients with relatively early stage (stages 0–II)
breast cancer with tumor size classiﬁed as Tis, T1, and
T2, the rate of local recurrence, survival, and incidence of
postoperative complications are equal to those achieved with
NSSM.
Compared with NSSM, SSM is far superior as regards
cosmetic outcomes and is expected to remarkably reduce the
emotional trauma due to the sense of loss of a breast that is
perceived by the patient just after surgery.
And in SSM, type C is considered far superior as regards
cost and cosmetic outcomes, because fewer patients desire to
receive postoperative nipple-areolar plasty.
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